Dialysis industry news

Stories from the dialysis comunity across the globe.



Characterization of membranous and cytoplasmic EGFR expression in human normal ... - UroToday PDF Print
UroTodayMetastatic renal cell carcinoma (RCC) is highly resistant to conventional systemic treatments, including chemotherapy, radiotherapy and hormonal therapies. ...Renal cell carcinoma in a 44-year-old man: an etiology for low back pain

... read more

 
Biochemical and pathological response of prostate cancer in a patient with ... - UroToday PDF Print
UroTodaySunitinib is a small molecular inhibitor of tyrosine kinases and is used to treat advanced renal cell carcinoma and gastrointestinal stromal tumour after

... read more

 
Inflammatory protein serum amyloid A1 marks a subset of conventional renal ... - UroToday PDF Print
UroTodayConventional renal cell carcinoma (RCC) is the most common renal cancer. As the metastatic conventional RCC is practically incurable, there is a need for

... read more

 
Ipsen Grants Menarini Exclusive European Licence Rights to Adenuric ... - Reuters PDF Print
ReutersAdditionally, Adenuric® can be prescribed without dose adjustment to patients suffering from mild to moderate renal impairment and might be an alternative

... read more

 
Dr. Spar joins dialysis clinic - Clarion News PDF Print
Clarion NewsDr. Spar completed his nephrology fellowship at the University of Pennsylvania in Philadelphia. Prior to relocating to the area with his wife and son,

... read more

 
<< Start < Prev 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 Next > End >>

Page 3499 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.